Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNN7W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,572
Award facts
- Contract value 100% obligated
- $21,572.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Wegovy 1.7 mg/0.75 mL pens valued at $21,572.18, with completion scheduled for December 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill competitive procurement requirements across diverse therapeutic domains, including specialty medications, diabetes treatments, and other critical pharmaceuticals. This delivery order for Wegovy, a GLP-1 receptor agonist used for weight management, exemplifies the company's role in supplying specialized pharmaceutical products to support Defense Health Agency operations and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26FNN7W?
SPE2DR26FNN7W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FNN7W worth?
The government has obligated $21,572 on SPE2DR26FNN7W.
Is contract SPE2DR26FNN7W an order under another contract?
Yes. SPE2DR26FNN7W is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNN7W competed?
The extent of competition for SPE2DR26FNN7W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award